Baker Bros. Advisors LP Summit Therapeutics Inc. Put Options Transaction History
Baker Bros. Advisors LP
- $9.02 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Vanguard Group Inc Valley Forge, PA11.7MShares$209 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$142 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$118 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$100 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.2MShares$57.4 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.61B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...